Skip to content

Tobacco Smoking Among Crosslinked-keratoconus Patients

Tobacco Smoking Among Crosslinked-keratoconus Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03462355
Acronym
TOBACOLINK
Enrollment
62
Registered
2018-03-12
Start date
2014-03-01
Completion date
2018-01-30
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Brief summary

Certain studies reported that cigarette by-products may make the cornea more rigid, suggesting that it could lead to natural CXL of collagen fibers, hence a protective effect for KC. Others have reported that cigarette smoking causes no significant changes in the corneal biomechanics. The aim of this study was to assess a possible link between keratoconus (KC) occurrence and patients' smoking habits.

Detailed description

a telephone Survey was performed among 80 KC patients who were treated from March 2014 until September 2017 by accelerated crosslinking (A-CXL) within the ophthalmology department. From the 80 people we phoned, 62 answered. Our questions were regarding family history, allergic history, and smoking habits. Family history was considered positive if a first-degree or second-degree relative had been diagnosed with KC. Allergies toward any kind of external factors were marked as positive. Patients' smoking habits were recorded and classified into regular, occasional, ex-smoker and non-smoker. The results were confronted to those of the general population by indirect standardization over age and sex according to the Baromètre Santé 2010 INPES survey (French Nation Institute for Prevention and Health Education).

Interventions

None listed

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients suffering from Keratoconus and needing Cross-linking therapy

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Percentage of smokersAfter 2 yearsPercentage of smokers among Cross-linked Keratoconus patients

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026